Jeffrey M Peppercorn

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi Does comparative effectiveness research promote rationing of cancer care?
    Jeffrey Peppercorn
    Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Duke University, Durham, NC, USA Electronic address
    Lancet Oncol 15:e132-8. 2014
  2. doi Rationing in urologic oncology: lessons from sipuleucel-T for advanced prostate cancer
    Jeffrey Peppercorn
    Duke University Medical Center, Durham, NC 27710, USA Electronic address
    Urol Oncol 31:1079-84. 2013
  3. pmc Ethics of ongoing cancer care for patients making risky decisions
    Jeffrey Peppercorn
    Duke University Medical Center, Durham, NC 27710, USA
    J Oncol Pract 8:e111-3. 2012
  4. doi Ethical aspects of participation in the database of genotypes and phenotypes of the National Center for Biotechnology Information: the Cancer and Leukemia Group B Experience
    Jeffrey Peppercorn
    Division of Medical Oncology, Duke University Medical Center, Durham, NC 27710, USA
    Cancer 118:5060-8. 2012
  5. pmc Rationale and design of the Exercise Intensity Trial (EXCITE): A randomized trial comparing the effects of moderate versus moderate to high-intensity aerobic training in women with operable breast cancer
    Lee W Jones
    Duke University Medical Center, Durham, NC, USA
    BMC Cancer 10:531. 2010
  6. doi American society of clinical oncology statement: toward individualized care for patients with advanced cancer
    Jeffrey M Peppercorn
    Division of Medical Oncology, Duke University Medical Center, Box 3446, Durham, NC 27710, USA
    J Clin Oncol 29:755-60. 2011
  7. doi Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology
    Jeffrey Peppercorn
    Division of Medical Oncology, Duke University Medical Center, Durham, NC 27710, USA
    J Clin Oncol 28:2635-40. 2010
  8. ncbi Breast cancer in women under 40
    Jeffrey Peppercorn
    Division of Medical Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Oncology (Williston Park) 23:465-74. 2009
  9. doi Self-reported practices and attitudes of US oncologists regarding off-protocol therapy
    Jeffrey Peppercorn
    Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, NC 27710, USA
    J Clin Oncol 26:5994-6000. 2008
  10. doi Erratum to: Exercise therapy in the management of solid tumors
    Lee W Jones
    Duke University Medical Center, Box 3085, Durham, NC 27710, USA
    Curr Treat Options Oncol 11:73-86. 2010

Detail Information

Publications15

  1. ncbi Does comparative effectiveness research promote rationing of cancer care?
    Jeffrey Peppercorn
    Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Duke University, Durham, NC, USA Electronic address
    Lancet Oncol 15:e132-8. 2014
    ..As we show, all health systems struggle to balance access to cancer care and control of costs; comparative effectiveness data can clarify choices, but does not itself determine policy or promote rationing of care. ..
  2. doi Rationing in urologic oncology: lessons from sipuleucel-T for advanced prostate cancer
    Jeffrey Peppercorn
    Duke University Medical Center, Durham, NC 27710, USA Electronic address
    Urol Oncol 31:1079-84. 2013
    ..There are no clear guidelines for how clinicians and medical centers should allocate scarce cancer care resources among patients who may benefit from the intervention...
  3. pmc Ethics of ongoing cancer care for patients making risky decisions
    Jeffrey Peppercorn
    Duke University Medical Center, Durham, NC 27710, USA
    J Oncol Pract 8:e111-3. 2012
    ..13 However, respect for the patient’s autonomy does not require support for inappropriate care and should not require that the oncologist check his or her professional judgment at the door...
  4. doi Ethical aspects of participation in the database of genotypes and phenotypes of the National Center for Biotechnology Information: the Cancer and Leukemia Group B Experience
    Jeffrey Peppercorn
    Division of Medical Oncology, Duke University Medical Center, Durham, NC 27710, USA
    Cancer 118:5060-8. 2012
    ....
  5. pmc Rationale and design of the Exercise Intensity Trial (EXCITE): A randomized trial comparing the effects of moderate versus moderate to high-intensity aerobic training in women with operable breast cancer
    Lee W Jones
    Duke University Medical Center, Durham, NC, USA
    BMC Cancer 10:531. 2010
    ....
  6. doi American society of clinical oncology statement: toward individualized care for patients with advanced cancer
    Jeffrey M Peppercorn
    Division of Medical Oncology, Duke University Medical Center, Box 3446, Durham, NC 27710, USA
    J Clin Oncol 29:755-60. 2011
    ....
  7. doi Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology
    Jeffrey Peppercorn
    Division of Medical Oncology, Duke University Medical Center, Durham, NC 27710, USA
    J Clin Oncol 28:2635-40. 2010
    ..We feel that if these principles are respected, an informed adult with cancer can both understand and voluntarily consent to participation in a clinical trial involving mandatory research biopsy for scientific end points...
  8. ncbi Breast cancer in women under 40
    Jeffrey Peppercorn
    Division of Medical Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Oncology (Williston Park) 23:465-74. 2009
    ..This manuscript focuses on the clinical decisions that we confront when considering systemic therapy for young women with early-stage breast cancer and the evolving data to guide the care of these patients...
  9. doi Self-reported practices and attitudes of US oncologists regarding off-protocol therapy
    Jeffrey Peppercorn
    Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, NC 27710, USA
    J Clin Oncol 26:5994-6000. 2008
    ..Investigational cancer therapies being tested in clinical trials may be available outside of trials, or off-protocol (OPRx). We evaluated the practices and attitudes among US oncologists with regard to this controversial practice...
  10. doi Erratum to: Exercise therapy in the management of solid tumors
    Lee W Jones
    Duke University Medical Center, Box 3085, Durham, NC 27710, USA
    Curr Treat Options Oncol 11:73-86. 2010
    ..Preliminary evidence in this area supports that exercise therapy may be an important consideration in multidisciplinary management of patients following a cancer diagnosis...
  11. doi Availability of experimental therapy outside oncology randomized clinical trials in the United States
    Erika P Hamilton
    Duke University Medical Center and Duke Comprehensive Cancer Center, Durham, NC, USA
    J Clin Oncol 28:5067-73. 2010
    ..We conducted a literature-based analysis of recent randomized trials to evaluate the potential scope and impact of OPRx in the United States...
  12. pmc CYP2D6 testing in breast cancer: ready for prime time?
    Nicole M Kuderer
    Division of Hematology, Oncology and Cellular Therapy, Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, North Carolina 27710, USA
    Oncology (Williston Park) 23:1223-32. 2009
    ..Anticipated data from retrospective analysis of large adjuvant randomized trials of tamoxifen should help address the clinical utility of CYP2D6 testing...
  13. doi Prevalence and impact of correlative science in breast cancer phase II trials
    Tian Zhang
    Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Box 3446, Durham, NC 27710, USA
    Breast Cancer Res Treat 139:845-50. 2013
    ..005). A minority of phase II breast cancer trials include CS representing a missed opportunity to learn more from clinical research. When CS is included, consistent reporting of endpoints, feasibility, outcomes, and safety is needed. ..
  14. pmc The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience
    S Yousuf Zafar
    Center for Learning Health Care, Duke Clinical Research Institute, Duke Cancer Institute, Durham, North Carolina 27710, USA
    Oncologist 18:381-90. 2013
    ..Our objective was to describe experiences of insured cancer patients requesting copayment assistance and to describe the impact of health care expenses on well-being and treatment...
  15. doi Symptom communication in breast cancer: relationships of holding back and self-efficacy for communication to symptoms and adjustment
    Sara N Edmond
    a Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA
    J Psychosoc Oncol 31:698-711. 2013
    ..Increased SE is beneficial among women on endocrine therapy for breast cancer. Future research should determine if interventions to improve SE are feasible and can improve QOL and symptom tolerability. ..